ビジョンケア市場調査レポート:製品タイプ別(コンタクトレンズ、眼鏡、眼内レンズ、コンタクトレンズソリューション、その他)、適応症(屈折異常、緑内障、糖尿病性網膜症、弱視、ドライアイ、その他)、治療別(手術、レーザー治療、投薬、その他)およびエンドユーザー(眼科病院)&クリニック、外来手術センター、光学店、その他)— 2030年までの予測
ID: MRFR/HC/6978-HCR | 127 Pages | Author: Rahul Gotadki| July 2025
As per MRFR Analysis, the Global Vision Care Market was valued at USD 173.5 billion in 2021 and is projected to reach USD 238 billion by 2032, growing at a CAGR of 4.3% from 2023 to 2032. Key drivers include increasing awareness of vision care benefits, a rising geriatric population, and the prevalence of visual impairments due to sedentary lifestyles and pollution. Technological advancements, such as the introduction of ZEISS VISUCORE 500, are transforming the consumer experience in the optical sector. The market is segmented by product type, indication, and treatment, with eyeglasses and glaucoma being significant contributors. North America leads the market, followed by Europe and Asia-Pacific, with the latter expected to grow at the fastest rate.
The Vision Care Market is witnessing significant growth driven by various factors.
ESSILORLUXOTTICA (France), Bausch Health (Canada), The Cooper Companies Inc (US), NOVARTIS AG (Switzerland), Cadila Healthcare (India), Johnson & Johnson Services Inc. (US), Rayner Surgical Group Limited (UK), Menicon (Japan), Carl-Zeiss-Stiftung (Germany)
ビジョンケア市場は、2030年までに2,37051.10百万米ドルを超え、CAGR 4.03%になると予想されています
ビジョンケアマーケットのあらすじ
視力ケアは、治療、化粧品の変更、および視力(目)に関連する他の手順、製品、およびサービスを扱う健康環境です。目は体の重要かつ重要な部分です。定期的に注意する必要があります。
したがって、健康な視力のために視力ケアが必要なのは他の理由の1つです。
若い人口の屈折異常は、予測期間中に増加すると予想されます。
ビジョンケア市場インフルエンサー
糖尿病性網膜症の主要な原因である糖尿病の有病率の上昇。
マーケットドライバー
市場制約
ビジョンケア市場セグメンテーション
製品タイプ別
製品タイプに基づく世界のビジョンケア市場は、コンタクトレンズ、眼鏡、眼内レンズ(IOL)、コンタクトレンズに大別されますソリューション、その他。
化粧品とライフスタイル志向のレンズは、人の美しさと外観を高めるための補助として使用されるコンタクトレンズです。これらのタイプのコンタクトレンズは、レンズのパワーとともに、色やデザインのパターンのカスタマイズに応じて利用できます
表示による
適応症に基づく世界のビジョンケア市場は、屈折異常、緑内障、糖尿病性網膜症、弱視、ドライアイなどに分けられます。
治療によって
治療に基づく世界的な視力ケア市場は、手術、投薬などに分割されています。
Report Attribute/Metric | Details |
Market Size 2021 | USD 173.5 billion |
Market Size 2022 | USD 180.49205 billion |
Market Size 2032 | USD 238 billion |
Compound Annual Growth Rate (CAGR) | 4.3% (2023-2032) |
Base Year | 2022 |
Market Forecast Period | 2023-2032 |
Historical Data | 2018 & 2020 |
Market Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product Type, Indication, Treatment, End User, and Region |
Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | ESSILORLUXOTTICA (France), Bausch Health [Canada] (Bausch & Lomb Incorporated), The Cooper Companies Inc [US] (Cooper Vision), NOVARTIS AG (Switzerland), Cadila Healthcare [India] (Zydus Pharmaceuticals Inc.), and others |
Key Market Opportunities | The growing awareness amongst the patients regarding the benefits of vision care |
Key Market Dynamics | Unhealthy diet and an increased incidence of chronic illness |
Frequently Asked Questions (FAQ) :
The global Vision Care market size was valued at USD 173.5 Billion in 2021.
The global market is projected to grow at a CAGR of 4.3% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are ESSILORLUXOTTICA (France), Bausch Health [Canada] (Bausch & Lomb Incorporated), The Cooper Companies Inc [US] (Cooper Vision), NOVARTIS AG (Switzerland), Cadila Healthcare [India] (Zydus Pharmaceuticals Inc.), and others.
The eyeglasses dominated the market in 2021.
The glaucoma had the largest share in the global market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)